Autoplaque vs eMurmur Heart AI
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your clinical workflow involves detailed, quantitative analysis of coronary CT angiography images to assess atherosclerotic plaque burden and luminal stenoses. This workstation-based software is ideal for cardiologists and radiologists focused on precise heart attack risk stratification and guiding treatment decisions based on advanced imaging insights.
View Autoplaque →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if you require an accessible, AI-powered solution for automated screening and monitoring of heart and lung sounds, particularly in primary care, telehealth, or remote patient monitoring settings. This cloud-based platform is best suited for quickly detecting and classifying heart murmurs and lung abnormalities using digital stethoscopes, offering hemodynamic insights and supporting remote consultations.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | eMurmur Heart AI |
|---|---|---|
| Pricing | Unknown | Contact for quote |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Web-based, Mobile App, API integration |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur Heart AIeMurmur Heart AI offers superior usability due to its cloud-based, web, and mobile deployment, providing greater flexibility and accessibility across various devices and care settings. Its features like live streaming and remote auscultation also enhance its utility for modern telehealth workflows. Autoplaque is workstation-based, which can be less flexible for diverse clinical environments.
Clinical Value
TieBoth tools offer significant and FDA-cleared clinical value in different domains. Autoplaque provides deep, quantitative insights for advanced cardiovascular risk stratification from CT imaging, which is critical for prevention and treatment planning. eMurmur Heart AI enhances a fundamental diagnostic method (auscultation) with AI, broadening its utility across multiple specialties and care settings for earlier detection and monitoring.
Pricing & Value
TieNeither tool discloses its pricing, making it impossible to conduct a head-to-head comparison or assess their respective value propositions. Without transparent pricing information, a definitive winner cannot be determined.
Enterprise Readiness
eMurmur Heart AIeMurmur Heart AI demonstrates stronger enterprise readiness with explicit HIPAA compliance and BAA availability, which are critical for healthcare organizations. Its cloud-based architecture also offers greater scalability and easier integration into existing IT infrastructures compared to Autoplaque's workstation-based solution.
Innovation
eMurmur Heart AIWhile Autoplaque offers sophisticated AI in imaging for quantitative plaque analysis, eMurmur Heart AI demonstrates broader innovation by transforming a traditional diagnostic method (auscultation) with AI, integrating it seamlessly into modern telehealth workflows, and ensuring hardware neutrality. This approach significantly enhances accessibility and utility across diverse clinical settings.
Support & Docs
eMurmur Heart AIeMurmur Heart AI appears to offer more robust support and documentation, evidenced by its dedicated teaching and training applications (eMurmur University and Primer) and its design for seamless integration into clinical workflows. While Autoplaque mentions a user manual, eMurmur's approach suggests a more comprehensive and accessible ecosystem for user education and assistance.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | eMurmur Heart AI |
|---|---|---|
| Name | Autoplaque | eMurmur Heart AI |
| Company | Cedars-Sinai Medical Center: AIM | CSD Labs |
| Description | Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | eMurmur Heart AI by CSD Labs is an FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings. |
| Key Features | AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area | Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes); Detection and classification of pathologic and innocent heart murmurs; Hemodynamic insights (loudness ratios of S1, systole, S2, diastole); Mobile app (iOS, Android) and web portal for access; Hardware-neutral and stethoscope agnostic platform compatibility; Live streaming and remote auscultation for telehealth; Recording, secure storage, and playback of auscultation data; Comparison of current and previous auscultation data for monitoring |
| Specialties | Cardiology, Radiology | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and eMurmur Heart AI.